GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.24+0.24 (+12.00%)
Close on Nov 18, 2026Market cap $101.35MP/E –Yield –
Genelux operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Genelux's operating cash flow for the twelve months ending Jun 30, 2026 was -$25.28M. For fiscal 2025 it was -$25.27M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.27M | – |
| FY2024 | Dec 31, 2024 | -$21.23M | – |
| FY2023 | Dec 31, 2023 | -$20.28M | – |
| FY2022 | Dec 31, 2022 | -$3.57M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.44M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.06M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.06M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.44M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.75M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.82M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.35M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.91M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.36M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.42M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.59M | -262.5% |
| Q4 FY2022 | Dec 31, 2022 | -$1.52M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.47M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.41M | – |
| Q1 FY2022 | Mar 31, 2022 | $2.83M | – |
See a number that looks wrong?